Article
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN.
Blood - 22 Sept 2022
Döhner Hartmut, Wei Andrew H, Appelbaum Frederick R, Craddock Charles, DiNardo Courtney D, Dombret Hervé, Ebert Benjamin L, Fenaux Pierre, Godley Lucy A, Hasserjian Robert P, Larson Richard A, Levine Ross L, Miyazaki Yasushi, Niederwieser Dietger, Ossenkoppele Gert, Röllig Christoph, Sierra Jorge, Stein Eytan M, Tallman Martin S, Tien Hwei-Fang, Wang Jianxiang, Wierzbowska Agnieszka, Löwenberg Bob
Abstract excerpt
The 2010 and 2017 editions of the European LeukemiaNet (ELN) recommendations for diagnosis and management of acute myeloid leukemia (AML) in adults are widely recognized among physicians and investigators. There have been major advances in our understanding of AML, including new knowledge about the molecular pathogenesis of AML, leading to an update of the disease classification, technological progress in genomic...
Topics
- Adult
- Antineoplastic Agents
- Humans
- Leukemia, Myeloid, Acute
- Mutation
- Neoplasm, Residual
- Nucleophosmin
- Prognosis
- Proto-Oncogene Proteins c-bcl-2